High-dose chemotherapy and autologous stem cell transplantation for secondary central nervous system lymphoma: many are called, but few are chosen

Cell Transplantation ◽

High Dose Chemotherapy ◽

High Dose ◽

Secondary Central Nervous System

High-dose chemotherapy supported by autologous stem cell transplantation in patients with primary central nervous system lymphoma: facts and opinions

Leukemia & Lymphoma ◽

10.1080/10428190802381238 ◽

2008 ◽

Vol 49 (11) ◽

pp. 2042-2047 ◽

Cited By ~ 37

Author(s):

Andrés J. M. Ferreri ◽

Roberto Crocchiolo ◽

Andrea Assanelli ◽

Silvia Govi ◽

Michele Reni

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Stem Cell ◽

Cell Transplantation ◽

High Dose Chemotherapy ◽

Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma

Annals of Hematology ◽

10.1007/s00277-019-03667-1 ◽

2019 ◽

Vol 98 (7) ◽

pp. 1657-1664 ◽

Cited By ~ 1

Author(s):

Jaewon Hyung ◽

Jung Yong Hong ◽

Dok Hyun Yoon ◽

Shin Kim ◽

Jung Sun Park ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Stem Cell ◽

Cell Transplantation ◽

High Dose Chemotherapy ◽

Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation

Haematologica ◽

10.3324/haematol.2012.076075 ◽

2013 ◽

Vol 98 (5) ◽

pp. 765-770 ◽

Cited By ~ 52

Author(s):

E. Schorb ◽

B. Kasenda ◽

J. Atta ◽

S. Kaun ◽

A. Morgner ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Stem Cell ◽

Cell Transplantation ◽

High Dose Chemotherapy ◽

Parkinsonism as a late presentation of lymphomatosis cerebri following high-dose chemotherapy with autologous stem cell transplantation for primary central nervous system lymphoma

Journal of Neurology ◽

10.1007/s00415-020-09819-y ◽

2020 ◽

Vol 267 (8) ◽

pp. 2239-2244

Author(s):

Sarah Merrill ◽

David J. Mauler ◽

Kent R. Richter ◽

Aditya Raghunathan ◽

Jose F. Leis ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Stem Cell ◽

High Dose Chemotherapy ◽

Late Presentation ◽

High Dose ◽

Lymphomatosis Cerebri

Durable Survival Outcomes in Primary and Secondary Central Nervous System Lymphoma After High-dose Chemotherapy and Autologous Stem Cell Transplantation Using a Thiotepa, Busulfan, and Cyclophosphamide Conditioning Regimen

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2020.02.009 ◽

2020 ◽

Vol 20 (7) ◽

pp. 468-479

Author(s):

Patricia A. Young ◽

Daria Gaut ◽

Davis K. Kimaiyo ◽

Jonathan Grotts ◽

Tahmineh Romero ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Stem Cell ◽

Conditioning Regimen ◽

High Dose Chemotherapy ◽

Survival Outcomes ◽

High Dose ◽

Secondary Central Nervous System

High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma: Data From the Japan Society for Hematopoietic Cell Transplantation Registry

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2019.01.020 ◽

2019 ◽

Vol 25 (5) ◽

pp. 899-905 ◽

Cited By ~ 4

Author(s):

Eisei Kondo ◽

Takashi Ikeda ◽

Koji Izutsu ◽

Dai Chihara ◽

Risa Shimizu-Koresawa ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Stem Cell ◽

Cell Transplantation ◽

Hematopoietic Cell Transplantation ◽

High Dose Chemotherapy ◽

High Dose ◽

Japan Society

An update on high-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.2043 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 2043-2043

Author(s):

Ryan Eldredge Wilcox ◽

Mark Robert Litzow ◽

Evanthia Galanis ◽

Paula Gill ◽

Jan C. Buckner

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Stem Cell ◽

Cell Transplantation ◽

High Dose Chemotherapy ◽

High Dose ◽

Embryonal Tumors ◽

The Central Nervous System

Excellent Outcomes in Patients with Primary and Secondary Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using a Rituximab, Busulfan, Melphalan, Thiotepa Conditioning Regimen

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00289-x ◽

2021 ◽

Vol 27 (3) ◽

pp. S232-S233

Author(s):

Shona A Philip ◽

Adrienne Fulford ◽

Selay Lam ◽

Chai Phua ◽

Joy Mangel ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Stem Cell ◽

Cell Transplantation ◽

Conditioning Regimen ◽

Secondary Central Nervous System

High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for pediatric primary central nervous system lymphoma in first complete remission

Cancer ◽

10.1002/cncr.30768 ◽

2017 ◽

Vol 123 (14) ◽

pp. 2781-2782

Author(s):

Revathi Rajagopal ◽

Gordon C. P. Miles ◽

Rishi S. Kotecha

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Stem Cell ◽

Complete Remission ◽

High Dose Chemotherapy ◽

High Dose ◽

First Complete Remission

Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas

Haematologica ◽

10.3324/haematol.2012.077917 ◽

2012 ◽

Vol 98 (3) ◽

pp. 364-370 ◽

Cited By ~ 64

Author(s):

A. Korfel ◽

T. Elter ◽

E. Thiel ◽

M. Hanel ◽

R. Mohle ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Stem Cell ◽

Cell Transplantation ◽

Phase Ii ◽

Phase Ii Study ◽

High Dose Chemotherapy ◽